InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Krasner Alan Seth, Directeur Médical. Officer active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been logged. The latest transaction was filed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
014,250 shares0
Common Stock
SEC:0001209191-22-015129:0·
€71,0236,700 shares@ €10.60050.0016% mcap100.0% of flow
Common Stock
SEC:0001209191-22-004453·
€71,0236,700 shares@ €10.60050.0016% mcap50.0% of flow
Common Stock
SEC:0001209191-22-004453:0·
3 of 3 declarations
About Krasner Alan Seth
Alan Seth Krasner is the Chief Medical Officer at Crinetics Pharmaceuticals, Inc. He is responsible for medical leadership and product development strategies. His role is essential in ensuring that Crinetics' products meet safety and efficacy standards.
